Analyst Report: COHR

1. EXECUTIVE SUMMARY

Coherent closed at $210.32 on Friday, down 11.34% from $237.22, in a sector-wide selloff of AI optics stocks that 24/7 Wall St. tied to worries about hyperscaler spending. The trigger cited was Alphabet's Google unit reporting negative free cash flow of $9.1bn against expectations of about -$3.5bn. Applied Optoelectronics, Lumentum and Marvell fell roughly 10% to 15% the same day, according to the same outlet, which points to a group move and not a company-specific event. The shares are 37.60% below their close 20 sessions ago, and fiscal Q1 2027 results arrive on November 4, so the next company-specific evidence on demand is days away. This is a re-rating of the group on customer capital spending, and Coherent's results will test whether the demand commentary from August still holds.

2. THE CATALYST

24/7 Wall St. reported on October 30 that the selloff hit AI optics names that afternoon, linking it to hyperscaler capex concerns after Google's negative free cash flow of $9.1bn and a loss of more than $500bn in Alphabet's market value on October 29. The outlet also described crowded AI winners seeing profit-taking after large gains this year. That is the outlet's interpretation, and the company disclosed nothing. The article put Coherent's intraday decline near 13%, and the session closed at -11.34% on volume of 11,949,200 shares, 1.79x the 50-session average.

Peers in the group moved the same way:

Marvell also carried exposure to Google's custom chips, per the same source. In the facts panel, the S&P 500 fell 1.82% on the day, and the electronic components peers GLW and APH fell 4.32% and 3.39% over the same period.

Earlier sessions set the backdrop. On October 22 the shares fell 12.51% to $207.82 in a broad tech and AI selloff, after Susquehanna cut its target to $350 from $425 (keeping a Positive rating) and Morningstar initiated on October 21 with a cautious view on valuation (Investing.com, StreetInsider). The stock then recovered to $239.59 by October 28, helped by a 5.83% gain on October 26 and 6.45% on October 27. StoneX initiated at Buy with a $425 target on October 26 (CNBC).

Bloomberg's report of advanced Marvell–Lumentum talks, an all-stock deal valuing Lumentum at about $83bn, was a cross-current on October 28 and 29. Neither company had confirmed it as of October 29 (24/7 Wall St.). Coherent shares were roughly flat that day, edging up on the idea that Lumentum's sold-out capacity could push customers toward Coherent.

3. COMPANY PROFILE

Coherent Corp. makes lasers, transceivers and other optical and optoelectronic devices, modules and systems. Its Datacenter and Communications segment sells transceivers, co-packaged optics and optical circuit switches. It sits in the Technology sector and competes in AI optics with Lumentum, Applied Optoelectronics and Marvell, per the research brief's sector coverage.

Recent results and guidance from the brief:

• Fiscal 2026 (year to June 30, 2026): revenue of $7.1bn and operating profit of $897.9m (Ad-hoc-news).
• On August 12, CEO Jim Anderson said the company saw no signs of slowing customer demand (24/7 Wall St., citing the August call).
• Management targets doubling six-inch indium phosphide laser capacity in the September quarter and more than doubling again by the end of 2027 (TradingView/StockStory; Markets Insider).
• PhotonLink platform revenue is expected to start ramping in the fourth quarter of calendar 2026 (TradingView/StockStory).
• NVIDIA invested $2bn in Coherent on March 2, 2026, the same day it took a stake in Lumentum (24/7 Wall St.).

The market capitalisation is $41.42bn, with a forward P/E of 15.1 and a trailing P/E of 57.6.

4. DEEP DIVE ANALYSIS

Do fundamentals justify the move? The brief contains no company-specific negative news for October 30. The fall followed customer spending worries, so the demand picture in the company's own numbers is unchanged until the November 4 report. The gap between the forward P/E of 15.1 and the trailing 57.6 shows that earnings are expected to rise sharply. That expectation is the exposure if hyperscaler budgets tighten.

Comparable episodes. The brief records a drop of nearly 10% around July 2026 when the whole AI photonics group sold off without company news, with Applied Optoelectronics down about 17% and Lumentum about 10% (TIKR). The stock also fell about 8% the day after its fiscal Q4 report on August 13 (MarketChameleon). Past earnings reactions were large in both directions: down 13.2% on August 13, 2025 against an implied 9.9%, up 18.7% on November 5, 2025 against an implied 9.8%, and up 21.8% on February 5, 2025 against an implied 14.5% (Investing.com).

Peer read-across. Applied Optoelectronics is the most exposed name, with its top 10 customers at 99% of Q2 2026 revenue and an at-the-market equity program in use (24/7 Wall St.). Lumentum's CEO said its optical components are sold out through early 2029, which helps explain why the group trades on customer capex.

Analyst targets. Targets in the brief range from $297 to $425, all above the $210.32 close:

An undated StockAnalysis page shows a B. Riley Neutral target of $262, which may be more recent than the October 15 cut, though this cannot be confirmed.

Bull case. Capacity doubling, PhotonLink ramping, NVIDIA's $2bn stake and Anderson's August demand comment support the growth path. A forward P/E of 15.1 leaves room for the shares to recover if the results confirm demand.

Bear case. Hyperscaler free cash flow is under pressure, the group is crowded after large gains, and Morningstar considers valuations elevated. Analyst target cuts from Susquehanna, B. Riley and Morgan Stanley show estimates drifting lower before the results.

5. TECHNICAL SNAPSHOT

The $210.32 close sits below both the 50-day average of $279.57 and the 200-day average of $296.52, and 52.2% below the 52-week high of $440.00 set on June 3, while remaining well above the 52-week low of $123.75. Nearest support is the October 22 close of $207.82, with the session low of $203.87 on October 30 beneath it. The nearest resistance is the $221.50 close from October 26. Volume of 11,949,200 was 1.79x the 50-session average, similar to the 12,538,400 on October 22, so both heavy selling days came with elevated participation.

6. RISK FACTORS

• Earnings reaction. The options market implied an 8.5% move around the November 4 release, and the stock beat the implied move in four of the past eight reports (Investing.com). Most sources say the report follows the NYSE close, though TipRanks shows before the open. The consensus is EPS of 1.97 and revenue of $2.30bn per the facts panel, with TipRanks showing 1.98.
• Hyperscaler capex. Further spending warnings from large customers would hit the whole group again.
• Marvell–Lumentum. An announcement could come as soon as the week of November 2, though talks could still collapse (24/7 Wall St.). The report is unconfirmed by either company.
• Lumentum results. Expected November 5, with the date unconfirmed (24/7 Wall St.).
• Positioning. Crowded holdings amplify moves in both directions, as the 12.51% and 11.34% falls on October 22 and 30 show.

7. ACTIONABLE OUTLOOK

Short term (1-2 weeks). The November 4 report dominates. The stock closed at $210.32, close to the $209.29 level of October 23, and has moved between $207.82 and $239.59 across the last eight sessions. Capacity commentary, guidance and any remarks on customer ordering will set direction. A result that matches the August demand message would favour a rebound toward the $221.50 resistance, and cautious customer language would put $207.82 and then $203.87 in play.

Medium term (1-3 months). The path follows hyperscaler capex signals and the delivery of the laser capacity doubling. Consensus targets sit above the current price, though the cuts show analysts lowering expectations. The next two earnings reactions from Lumentum and the Marvell deal outcome will shape group sentiment.

Long term. The thesis rests on AI connectivity demand, capacity expansion and the PhotonLink ramp, and nothing in the brief changes it. The October 30 fall came from a sector spending concern and no company disclosure. This is analysis and not personal financial advice.